Barchart on MSN

Earnings Preview: What to Expect From Bio-Techne's Report

Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m. CST to review its first quarter fiscal 2026 ...
TipRanks on MSN

Bio-Techne price target raised to $70 from $65 at TD Cowen

TD Cowen analyst Kyle Boucher raised the firm’s price target on Bio-Techne (TECH) to $70 from $65 and keeps a Buy rating on the shares. The firm ...

Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution ...
Twin Cities Business

Bio-Techne Agrees to Buy Texas Testing Company for Up to $320M

Minneapolis-based life sciences firm Bio-Techne Corp. on Wednesday said it’s reached a deal to buy Austin, Texas-based Asuragen for up to $320 million. Under the terms of the deal, Bio-Techne will pay ...

5 Analysts Assess Bio-Techne: What You Need To Know

Ratings for Bio-Techne (NASDAQ: TECH) were provided by 5 analysts in the past three months, showcasing a mix of bullish and ...
Morningstar

Bio-Techne Announces Exosome Diagnostics Divestiture

MINNEAPOLIS, Aug. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx ...
Nasdaq

BIO-TECHNE TO ACQUIRE LUNAPHORE

MINNEAPOLIS and TOLOCHENAZ, Switzerland, June 22, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the ...
Business Insider

Here's what to expect from Bio-Techne's earnings

Bio-Techne will report earnings from the most recent quarter on October 31. Wall Street analysts predict earnings per share of $0.435. Track Bio-Techne stock price in real-time ahead here. On October ...

Bio-Techne (TECH): Valuation Spotlight Following Expanded Oxford Nanopore Partnership and Growth Strategy Realignment

Bio-Techne (TECH) made headlines by announcing an expanded partnership with Oxford Nanopore Technologies. This move extends their collaboration through 2032 and empowers Bio-Techne to broaden its ...
Morningstar

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

MINNEAPOLIS, June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP ...

Bio-Techne Corp. stock underperforms Thursday when compared to competitors

Bio-Techne Corp. closed 25.87% short of its 52-week high of $80.80, which the company reached on November 6th.